Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Obstetrics and Gynaecology Research|July 31, 2022
The incidence of cervical cancer in women with postcoital bleeding and abnormal appearance of the cervix referred through the 2-week wait pathway in the United Kingdom: A retrospective cohort studyBrittany Jasper, Emma Thorley, Filipe Correia Martins, et al.Frontiers in Bioscience (Elite Edition)|December 29, 2011
Microdialysis: improving local chemotherapy in cancer using a mathematical modelFilipe Correia Martins, Jose Luis Santos, Carlos Freire de OliveiraMelanoma Management|January 17, 2024
Organ-sparing central pelvic compartment resection for the treatment of vulvo-vaginal melanomasMark McGowan, Brent O'Carrigan, Filipe Correia Martins, et al.Tumori|March 11, 2011
Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancyFilipe Correia Martins, Maria Filomena Botelho, António Manuel Cabrita, et al.International Journal of Medical Informatics|December 8, 2023
Can natural language processing be effectively applied for audit data analysis in gynaecological oncology at a UK cancer centre?Mark McGowan, Filipe Correia Martins, Jodi-Louise Keen, et al.Elife|May 11, 2023
High-grade serous ovarian carcinoma organoids as models of chromosomal instabilityMaria Vias, Lena Morrill Gavarró, Carolin M Sauer, et al.Nature Communications|October 16, 2023
Molecular landscape and functional characterization of centrosome amplification in ovarian cancerCarolin M Sauer, James A Hall, Dominique-Laurent Couturier, et al.Nature Communications|October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancerFilipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.Nature Genetics|June 23, 2025
Predicting resistance to chemotherapy using chromosomal instability signaturesJoe Sneath Thompson, Laura Madrid, Barbara Hernando, et al.Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.Pageof 2